1. C.W. Tsao, A.W. Aday, Z.I. Almarzooq, A. Alonso, A.Z. Beaton et al. Heart disease and stroke statistics 2022 update: a report from the American Heart Association. Circulation 145, e153–e639 (2022)
2. D.K. Arnett, R.S. Blumenthal, M.A. Albert, A.B. Buroker, Z.D. Goldberger et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 140, e596–e646 (2019)
3. S.M. Grundy, N.J. Stone, A.L. Bailey, C. Beam, K.K. Birtcher et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139, e1082–e1143 (2019)
4. M.K. Cheeley, J.J. Saseen, A. Agarwala, S. Ravilla, N. Ciffone et al. NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient. J. Clin. Lipido. 16, 361–375 (2022)
5. R.H. Eckel, Approach to the patient who is intolerant of statin therapy. J. Clin. Endocrinol. Metab. 95, 2015–2022 (2010)